Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by Tort Defenders’ writers and staff and is as accurate as possible. This content should not be taken as legal advice from an attorney.
For years, Zantac (ranitidine) was one of the most commonly used medications for treating heartburn, acid reflux, and other gastrointestinal issues. Millions of people relied on it for relief, whether by prescription or over the counter. However, alarming evidence has emerged linking Zantac to a significant increase in cancer risk.
What is Zantac?
Zantac, also known by its generic name ranitidine, was introduced in the 1980s and quickly became a top-selling drug for treating conditions related to excess stomach acid, such as heartburn, gastroesophageal reflux disease (GERD), and ulcers. It belongs to a class of drugs called H2 blockers, which reduce the amount of acid produced by the stomach.
While it was considered safe for decades, recent investigations have revealed that Zantac contains or breaks down into a dangerous chemical called N-nitrosodimethylamine (NDMA), a substance that has been linked to cancer.
The Discovery of NDMA in Zantac
NDMA is a known carcinogen, meaning it is a chemical that can cause cancer in humans. It is classified by the World Health Organization (WHO) and the Environmental Protection Agency (EPA) as a potent cancer-causing agent. NDMA is found in very small amounts in some foods and water, but exposure to high levels of NDMA is considered dangerous.
In 2019, concerns about the safety of Zantac escalated when the U.S. Food and Drug Administration (FDA) announced that they had detected unacceptable levels of NDMA in ranitidine products. Subsequent testing revealed that the levels of NDMA in Zantac could increase over time or when the drug was stored at higher temperatures. This discovery sent shockwaves through the medical community and prompted recalls of Zantac and other ranitidine-based medications.
How NDMA Causes Cancer
NDMA is harmful because it damages DNA, leading to mutations that can result in cancer. When Zantac is taken, the ranitidine molecule can break down and form NDMA inside the body. Additionally, NDMA can increase in concentration over time as the medication sits on shelves, especially when exposed to heat or humidity.
Long-term exposure to NDMA is known to cause several types of cancer, including:
- Stomach cancer
- Liver cancer
- Kidney cancer
- Bladder cancer
- Colorectal cancer
- Pancreatic cancer
The potential for ranitidine to produce dangerous levels of NDMA when exposed to common conditions, such as warm temperatures, raises significant health concerns for those who used Zantac.
Scientific Studies Supporting Zantac and Cancer Link
Several scientific studies have reinforced the connection between Zantac and cancer due to the formation of NDMA. A pivotal study conducted in 2016 revealed that NDMA could be produced in the human body when ranitidine interacts with stomach acid. The researchers found that after just one dose of ranitidine, the levels of NDMA in the participants’ urine increased by more than 400 times the acceptable daily limit set by the FDA.
Moreover, a 2020 study published in JAMA Network confirmed the potential of ranitidine to form NDMA under conditions commonly found in the human digestive system. These findings prompted a growing concern among healthcare professionals and regulatory agencies regarding the long-term safety of Zantac use.
FDA Announcement and Zantac Recall
In April 2020, the FDA took decisive action by requesting all manufacturers to immediately withdraw Zantac and ranitidine products from the market. The agency stated that the risks posed by NDMA contamination were too great and advised consumers to stop using the drug. The FDA’s decision followed earlier voluntary recalls by several major pharmaceutical companies.
The recall and market withdrawal sent a clear message: Zantac posed a serious and underappreciated health risk. With millions of people having used the drug over the years, questions surrounding the extent of the damage caused by NDMA exposure have become a focal point of concern.
Lawsuits Against Zantac Manufacturers
The discovery of NDMA in Zantac has led to a wave of lawsuits filed by people who developed cancer after using the drug for an extended period. These lawsuits claim that drug manufacturers failed to adequately warn consumers about the potential risks of NDMA contamination, despite knowing about the dangers for years.
Thousands of Zantac users who developed cancer are now suing drugmakers, including Sanofi and GlaxoSmithKline, the primary manufacturers of the medication. The lawsuits argue that these companies did not take appropriate steps to ensure the safety of the drug and did not inform the public about the potential risks associated with long-term use.
Key Zantac Legal Developments
In 2021, a federal judge ruled that consolidated lawsuits could move forward. These lawsuits are part of what is known as a multidistrict litigation (MDL), which allows many similar cases to be grouped together for more efficient handling. This ruling has paved the way for thousands of Zantac cancer cases to proceed to trial.
The plaintiffs in these cases claim that the prolonged use of Zantac, often for years, led to the development of cancers such as bladder cancer, stomach cancer, and kidney cancer. Many of these individuals were unaware of the potential dangers until the FDA’s recall and are now seeking compensation for medical expenses, pain and suffering, and loss of quality of life.
What to Do If You’ve Been Affected
Act Quickly: There may be time limits on filing a claim, so it’s important to act as soon as possible. A lawyer can help ensure that you meet all necessary deadlines.
Seek Medical Advice: If you’ve taken Zantac regularly and are concerned about the potential risks, consult with your healthcare provider. They can guide you on what tests or screenings may be necessary based on your history.
Document Your Use: Gather any records of your Zantac use, including prescriptions or receipts. This information will be important if you decide to pursue legal action.
Contact a Lawyer: Speak with a lawyer who specializes in pharmaceutical lawsuits. Many law firms are currently handling Zantac cancer cases and can help you understand your rights and potential for compensation.